Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
SANDOZ PRAVASTATIN TABLETS | SANDOZ CANADA INCORPORATED | Resolved | 20MG | Updated Report | 2024-05-18 | 224645 |
SANDOZ PRAVASTATIN TABLETS | SANDOZ CANADA INCORPORATED | Resolved | 40MG | Updated Report | 2024-05-18 | 224648 |
VISIPAQUE 270 | GE HEALTHCARE CANADA INC | Resolved | 550MG | Updated Report | 2024-05-18 | 227151 |
SANDOZ SENNA S | SANDOZ CANADA INCORPORATED | Resolved | 50MG 8.6MG | Updated Report | 2024-05-18 | 227201 |
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | SANDOZ CANADA INCORPORATED | Resolved | 10000UNIT | Updated Report | 2024-05-18 | 227194 |
CALCIMAR | SANOFI-AVENTIS CANADA INC | Resolved | 200UNIT | Updated Report | 2024-05-18 | 167224 |
ATIVAN | PFIZER CANADA ULC | Actual shortage | 1MG | Updated Report | 2024-05-18 | 210722 |
AURO-VALACYCLOVIR | AURO PHARMA INC | Actual shortage | 500MG | Updated Report | 2024-05-18 | 227536 |
GABAPENTIN CAPSULES USP | ACCORD HEALTHCARE INC | Actual shortage | 400MG | Updated Report | 2024-05-18 | 228242 |
ADENOSINE INJECTION | FRESENIUS KABI CANADA LTD | Resolved | 3MG | Updated Report | 2024-05-18 | 222725 |
ENERZAIR BREEZHALER | NOVARTIS PHARMACEUTICALS CANADA INC | Actual shortage | 160MCG 50MCG 150MCG | Updated Report | 2024-05-17 | 228307 |
SENSORCAINE | ASPEN PHARMACARE CANADA INC. | Anticipated shortage | 5MG | New Report | 2024-05-17 | 228304 |
BIAXIN | BGP PHARMA ULC | Resolved | 250MG | Updated Report | 2024-05-17 | 215507 |
MYLAN-ATOVAQUONE/PROGUANIL | MYLAN PHARMACEUTICALS ULC | Anticipated shortage | 100MG 250MG | New Report | 2024-05-17 | 228299 |
OXYTOCIN INJECTION, USP | FRESENIUS KABI CANADA LTD | Actual shortage | 10UNIT | Updated Report | 2024-05-17 | 225346 |
TEVA-BUPROPION XL | TEVA CANADA LIMITED | Actual shortage | 300MG | Updated Report | 2024-05-17 | 223856 |
TEVA-BUPROPION XL | TEVA CANADA LIMITED | Actual shortage | 300MG | Updated Report | 2024-05-17 | 224445 |
LITHMAX | AA PHARMA INC | Actual shortage | 300MG | Updated Report | 2024-05-17 | 221857 |
SENSORCAINE | ASPEN PHARMACARE CANADA INC. | Anticipated shortage | 5MG | Updated Report | 2024-05-17 | 222686 |
SENSORCAINE WITH EPINEPHRINE | ASPEN PHARMACARE CANADA INC. | Anticipated shortage | 5MCG 2.5MG | New Report | 2024-05-17 | 228282 |
SENSORCAINE WITH EPINEPHRINE | ASPEN PHARMACARE CANADA INC. | Anticipated shortage | 2.5MG 5MCG | Updated Report | 2024-05-17 | 222678 |
LITHANE | SEARCHLIGHT PHARMA INC | Anticipated shortage | 300MG | Updated Report | 2024-05-17 | 228275 |
COTAZYM | ORGANON CANADA INC. | Anticipated shortage | 35000UNIT 40000UNIT 10000UNIT | Updated Report | 2024-05-17 | 225096 |
NUCYNTA EXTENDED-RELEASE | ENDO OPERATIONS LTD. | Actual shortage | 200MG | Updated Report | 2024-05-17 | 205952 |
TOBI | BGP PHARMA ULC | Actual shortage | 300MG | Updated Report | 2024-05-17 | 192953 |
MYLAN-GLICLAZIDE MR | MYLAN PHARMACEUTICALS ULC | Actual shortage | 30MG | Updated Report | 2024-05-17 | 224058 |
APO-VARENICLINE | APOTEX INC | Actual shortage | 1MG | Updated Report | 2024-05-17 | 225764 |
APO-TAMOX TAB 20MG | APOTEX INC | Actual shortage | 20MG | Updated Report | 2024-05-17 | 224990 |
APO-RIVASTIGMINE | APOTEX INC | Resolved | 3MG | Updated Report | 2024-05-17 | 227085 |
APO-MELOXICAM | APOTEX INC | Actual shortage | 1.5G | Updated Report | 2024-05-17 | 218379 |
APO-GLICLAZIDE MR | APOTEX INC | Actual shortage | 60MG | Updated Report | 2024-05-17 | 217481 |
APO-FLUVOXAMINE | APOTEX INC | Resolved | 100MG | Updated Report | 2024-05-17 | 224592 |
APO-DOMPERIDONE | APOTEX INC | Resolved | 10MG | Updated Report | 2024-05-17 | 227076 |
APO-CYCLOBENZAPRINE | APOTEX INC | Resolved | 10MG | Updated Report | 2024-05-17 | 227091 |
APO-BISOPROLOL | APOTEX INC | Actual shortage | 5MG | Updated Report | 2024-05-17 | 225023 |
APO-BACLOFEN | APOTEX INC | Actual shortage | 20MG | Updated Report | 2024-05-17 | 222455 |
APO-BACLOFEN | APOTEX INC | Actual shortage | 10MG | Updated Report | 2024-05-17 | 225011 |
APO-BACLOFEN | APOTEX INC | Actual shortage | 10MG | Updated Report | 2024-05-17 | 221696 |
APO-ATORVASTATIN | APOTEX INC | Actual shortage | 80MG | Updated Report | 2024-05-17 | 227088 |
APO-AMLODIPINE-ATORVASTATIN | APOTEX INC | Actual shortage | 80MG 10MG | Updated Report | 2024-05-17 | 219843 |
SUPREFACT DEPOT 3 MONTHS | CHEPLAPHARM ARZNEIMITTEL GMBH | Resolved | 9.45MG | Updated Report | 2024-05-17 | 207981 |
VENLAFAXINE XR | SANIS HEALTH INC | Resolved | 37.5MG | Updated Report | 2024-05-17 | 225878 |
VIIBRYD | ABBVIE CORPORATION | Actual shortage | 20MG | Updated Report | 2024-05-17 | 228152 |
SERTRALINE | SANIS HEALTH INC | Resolved | 100MG | Updated Report | 2024-05-17 | 216254 |
SERTRALINE | SANIS HEALTH INC | Resolved | 25MG | Updated Report | 2024-05-17 | 216264 |
SERTRALINE | SANIS HEALTH INC | Resolved | 50MG | Updated Report | 2024-05-17 | 217783 |
RISPERIDONE | SANIS HEALTH INC | Resolved | 0.25MG | Updated Report | 2024-05-17 | 223270 |
NASONEX | ORGANON CANADA INC. | Resolved | 50MCG | Updated Report | 2024-05-17 | 224304 |
SOLU-CORTEF | PFIZER CANADA ULC | Resolved | 250MG | Updated Report | 2024-05-17 | 225355 |
FLUOXETINE | SANIS HEALTH INC | Resolved | 20MG | Updated Report | 2024-05-17 | 164466 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | SANDOZ CANADA INCORPORATED | Discontinued | 10000UNIT | Updated Report | 2024-05-18 | 228249 |
SANDOZ PRAVASTATIN TABLETS | SANDOZ CANADA INCORPORATED | Discontinued | 20MG | Updated Report | 2024-05-18 | 228256 |
SANDOZ PRAVASTATIN TABLETS | SANDOZ CANADA INCORPORATED | Discontinued | 40MG | Updated Report | 2024-05-18 | 228263 |
SANDOZ SENNA S | SANDOZ CANADA INCORPORATED | Discontinued | 50MG 8.6MG | Updated Report | 2024-05-18 | 228268 |
SUPREFACT DEPOT 3 MONTHS | CHEPLAPHARM ARZNEIMITTEL GMBH | Discontinued | 9.45MG | Updated Report | 2024-05-17 | 228166 |
ANANDRON | CHEPLAPHARM ARZNEIMITTEL GMBH | Discontinued | 50MG | Updated Report | 2024-05-17 | 228155 |
FOSRENOL | TAKEDA CANADA INC | To be discontinued | 1000MG | New Report | 2024-05-16 | 228184 |
FOSRENOL | TAKEDA CANADA INC | To be discontinued | 750MG | New Report | 2024-05-16 | 228181 |
FOSRENOL | TAKEDA CANADA INC | To be discontinued | 500MG | New Report | 2024-05-16 | 228178 |
SUPREFACT DEPOT 2 MONTHS | CHEPLAPHARM ARZNEIMITTEL GMBH | To be discontinued | 6.3MG | New Report | 2024-05-16 | 228169 |
EYE STREAM | ALCON CANADA INC | Discontinued | 0.03% 0.048% 0.075% 0.64% | New Report | 2024-05-15 | 228021 |
MYLAN-NITRO SUBLINGUAL SPRAY | MYLAN PHARMACEUTICALS ULC | Discontinued | 0.4MG | New Report | 2024-05-08 | 227338 |
CHAMPIX | PFIZER CANADA ULC | Discontinued | 1MG 0.5MG | New Report | 2024-05-03 | 227052 |
CHAMPIX | PFIZER CANADA ULC | Discontinued | 1MG | New Report | 2024-05-03 | 227049 |
CHAMPIX | PFIZER CANADA ULC | Discontinued | 0.5MG | New Report | 2024-05-03 | 227046 |
AUBAGIO | SANOFI-AVENTIS CANADA INC | To be discontinued | 14MG | New Report | 2024-05-02 | 226847 |
SANDOZ OXYCODONE/ACETAMINOPHEN | SANDOZ CANADA INCORPORATED | Discontinued | 325MG 5MG | Updated Report | 2024-05-02 | 226748 |
SANDOZ OXYCODONE/ACETAMINOPHEN | SANDOZ CANADA INCORPORATED | Discontinued | 325MG 5MG | Updated Report | 2024-05-02 | 226753 |
HUMULIN R | ELI LILLY CANADA INC | To be discontinued | 100UNIT | New Report | 2024-05-02 | 224344 |
SANDOZ D 10 000 | SANDOZ CANADA INCORPORATED | Discontinued | 10000UNIT | Updated Report | 2024-05-02 | 226738 |